The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.1 - Manufacture of basic pharmaceutical products
400 jobs Number of planned job losses
Announcement Date
18 September 2018
Employment effect (start)
1 October 2018
Foreseen end date
Description
The Danish pharma group Novo Nordisk has announced to cut 400 positions in its research and development (R&D) services in Denmark and China. Novo Nordisk, which is the world’s biggest insulin maker, has decided to refocuses its R&D efforts on 'transformational biological and technological innovation'. Therefore, administrative staff, laboratory technicians and scientists working in the R&D services will be laid off in Denmark and China. But Novo Nordisk will also hire specialists in areas such as computational biology, stem cells and new disease areas (but the number of job creations is not known). The company has decided to reorganise the structure of its R&D organisation, creating internally four research units based in Denmark, the US and the UK. These units will operate as satellites of the company’s central R&D function. Novo Nordisk employs more than 43,000 people worldwide.
Sources
Citation
Eurofound (2018), Novo Nordisk, Internal restructuring in World, factsheet number 95497, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/95497.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...